These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19322687)

  • 1. [Prevention of migraine: a pharmacoepidemiological study].
    López Hernández N; Morera Guitart J; Medrano Martínez V; Fernández Izquierdo S; Pérez Sempere A
    Neurologia; 2009 Mar; 24(2):98-101. PubMed ID: 19322687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug treatment of migraine: Part II. Preventive therapy.
    Noble SL; Moore KL
    Am Fam Physician; 1997 Dec; 56(9):2279-86. PubMed ID: 9402813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive migraine treatment.
    Silberstein SD
    Neurol Clin; 2009 May; 27(2):429-43. PubMed ID: 19289224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraines with and without aura and their response to preventive therapy with topiramate.
    Reuter U; Sanchez Del Rio M; Diener HC; Allais G; Davies B; Gendolla A; Pfeil J; Schwalen S; Schäuble B; van Oene J
    Cephalalgia; 2010 May; 30(5):543-51. PubMed ID: 19732072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determinants of prophylactic migraine therapy in Spain].
    Pascual-Gómez J; Caminero AB; Cano A; Heras-Pérez JA; Leira-Muiño R; García-Ribas G;
    Rev Neurol; 2007 Nov 1-15; 45(9):513-8. PubMed ID: 17979079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which therapy for which patient?
    Pierangeli G; Cevoli S; Sancisi E; Grimaldi D; Zanigni S; Montagna P; Cortelli P
    Neurol Sci; 2006 May; 27 Suppl 2():S153-8. PubMed ID: 16688621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Developments in the Prophylactic Drug Treatment of Pediatric Migraine: What Is New in 2017 and Where Does It Leave Us?
    Kacperski J; Bazarsky A
    Curr Pain Headache Rep; 2017 Aug; 21(8):38. PubMed ID: 28779443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States.
    Woolley JM; Bonafede MM; Maiese BA; Lenz RA
    Headache; 2017 Oct; 57(9):1399-1408. PubMed ID: 28842990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
    Yaldo AZ; Wertz DA; Rupnow MF; Quimbo RM
    Clin Ther; 2008 Dec; 30(12):2452-60. PubMed ID: 19167603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and determinants of migraine prophylactic medication in the Netherlands.
    Rahimtoola H; Buurma H; Tijssen CC; Leufkens HG; Egberts AC
    Eur J Clin Pharmacol; 2002 May; 58(2):149-55. PubMed ID: 12012149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological basis of migraine prophylaxis.
    Galletti F; Cupini LM; Corbelli I; Calabresi P; Sarchielli P
    Prog Neurobiol; 2009 Oct; 89(2):176-92. PubMed ID: 19654035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine.
    Keskinbora K; Aydinli I
    Clin Neurol Neurosurg; 2008 Dec; 110(10):979-84. PubMed ID: 18620801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of medications used in treating headache.
    Solomon GD
    Semin Pediatr Neurol; 1995 Jun; 2(2):165-77. PubMed ID: 9422244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylactic treatments of migraine].
    Massiou H
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S79-86. PubMed ID: 11139754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of pharmacotherapy for the prevention of migraine: a Markov model application.
    Yu J; Smith KJ; Brixner DI
    CNS Drugs; 2010 Aug; 24(8):695-712. PubMed ID: 20658800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate for patients with refractory migraine: an observational, multicenter study in Spain.
    Pascual J; Sánchez del Rio M; Mateos V; Láinez JM; Hernández-Gallego J; Leira R; Jiménez MD
    Neurologia; 2003 Sep; 18(7):364-7. PubMed ID: 14505244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive treatment of migraine.
    Silberstein SD
    Rev Neurol Dis; 2005; 2(4):167-75. PubMed ID: 16622394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic pharmacotherapy of migraine. Some practical guidelines.
    Tfelt-Hansen P
    Neurol Clin; 1997 Feb; 15(1):153-65. PubMed ID: 9058403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preventive treatment with topiramate enhances the quality of life of patients with migraine].
    Medrano V; Sempere AP; Morera-Guitart J; Fernandez-Izquierdo S; Espinosa-Martinez J
    Rev Neurol; 2006 Sep 1-15; 43(5):259-63. PubMed ID: 16941422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.